Codes / ICD10CM / T49.1X5A

T49.1X5A Adverse effect of antipruritics, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of antipruritics, initial encounter (ICD Code: T49.1X5A)

Summary

This condition describes an adverse reaction to antipruritic medications—drugs used to relieve itching—occurring during the initial encounter with the healthcare provider. It includes unintended harm from these agents, such as allergic reactions, drug interactions, or sensitivity to ingredients, when used as prescribed or appropriately.

Causes

Adverse effects may result from allergic reactions, drug interactions, or sensitivity to antipruritic ingredients. These reactions can occur even with proper use, due to individual patient factors or unexpected responses to the medication.

Risk Factors

  • History of allergic reactions to similar agents or ingredients.
  • Concurrent use of multiple topical or systemic medications without awareness of ingredient overlap.
  • Impaired skin integrity (e.g., open wounds) increasing absorption risk.
  • Lack of supervision during medication use, especially in children or elderly patients.

Symptoms

Symptoms vary by agent and exposure: local reactions (rash, itching, burning) for adverse effects; systemic signs (nausea, dizziness) if absorbed. Severe cases may involve organ toxicity or anaphylaxis.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, medication history, and potential exposure details. Healthcare providers assess the timing of symptoms relative to antipruritic use and rule out other causes to confirm the adverse effect.

Treatment Options

Treatment focuses on managing symptoms and discontinuing the offending agent. For mild reactions, topical or oral antihistamines may be used. Severe cases may require corticosteroids, epinephrine for anaphylaxis, or supportive care.

Prognosis and Follow-Up

Prognosis is generally favorable with prompt treatment. Follow-up ensures resolution of symptoms and monitors for delayed reactions. Patients are advised to avoid the causative agent and report any new symptoms.

Complications

Complications may include severe allergic reactions (e.g., anaphylaxis), skin infections from scratching, or systemic toxicity if absorbed. Delayed treatment can worsen outcomes.

Lifestyle & Prevention

  • Avoid known allergens or irritants in antipruritic products.
  • Follow dosing instructions carefully and avoid overuse.
  • Inform healthcare providers of all medications, including topical agents.
  • Use products with fewer potential allergens when possible.

When to Seek Professional Help

Seek immediate care for severe symptoms (e.g., difficulty breathing, swelling, dizziness) or if symptoms worsen despite initial treatment. Contact a provider for persistent or new reactions.

Tips for Medical Coders

Document the specific antipruritic agent, timing of the adverse effect relative to use, and whether this is the initial encounter. Include details on symptom onset, treatment provided, and any known allergies or prior reactions to support coding accuracy.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

T49.1X5A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.